Quadrant Capital Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14
| Closed | -$55 | – | 2810 |
|
|
2024
Q4 | $55 | Sell |
14
-356
| -96% | -$1.4K | ﹤0.01% | 2728 |
|
|
2024
Q3 | $2.42K | Buy |
+370
| New | +$2.42K | ﹤0.01% | 2467 |
|
|
2019
Q2 | – | Sell |
-137
| Closed | -$4K | – | 2370 |
|
|
2019
Q1 | $4K | Hold |
137
| – | – | ﹤0.01% | 1923 |
|
|
2018
Q4 | $8K | Hold |
137
| – | – | ﹤0.01% | 1469 |
|
|
2018
Q3 | $19K | Hold |
137
| – | – | 0.01% | 1011 |
|
|
2018
Q2 | $16K | Hold |
137
| – | – | 0.01% | 1065 |
|
|
2018
Q1 | $12K | Hold |
137
| – | – | ﹤0.01% | 1178 |
|
|
2017
Q4 | $7K | Hold |
137
| – | – | ﹤0.01% | 1345 |
|
|
2017
Q3 | $5K | Hold |
137
| – | – | ﹤0.01% | 1476 |
|
|
2017
Q2 | $5K | Hold |
137
| – | – | ﹤0.01% | 1353 |
|
|
2017
Q1 | $7K | Hold |
137
| – | – | ﹤0.01% | 1215 |
|
|
2016
Q4 | $5K | Buy |
+137
| New | +$5K | ﹤0.01% | 1245 |
|